-65.7%
MRNA vs GPC
+29.4%
-95.1%
-95.1%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | GPC | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | -0.4% | +5.7% | +5.6% |
| 7D | -1.1% | -3.2% | +2.1% | +0.8% |
| 30D | +126.1% | +0.5% | +125.6% | +127.0% |
| 3M | +190.0% | +31.7% | +158.3% | +154.0% |
| 6M | +157.2% | +24.7% | +132.5% | +130.7% |
| YTD | +388.2% | +11.8% | +376.4% | +349.5% |
| 1Y | +467.0% | -3.0% | +470.0% | +464.1% |
| 3Y | +36.1% | -1.1% | +37.2% | +28.9% |
| All | -65.7% | +29.4% | -95.1% | -75.7% |
Cumulative growth
Daily Returns
Daily percentage return beside GPC.
Daily Out/Under-Performance
Portfolio return minus GPC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GPC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded GPC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling